
Strazza Watched for Failed Breakouts as Parets Held His Winners
The June 4, 2025 Morning Show paired Parets' conviction in the recovery with Strazza's concern about speculative stocks fading after strong news.
19 ideas
Latest ideas

The June 4, 2025 Morning Show paired Parets' conviction in the recovery with Strazza's concern about speculative stocks fading after strong news.

After Netflix, Disney and a biotech ETF failed his shorter-term trades, Lund described the intraday conditions he wanted to see improve before buying again. Mary Thwaites was also reducing short-term exposure while keeping longer-term positions.

After a sharp divergence between small stocks and megacaps, Singleton favored biotech and broader risk exposure. JC Parets pushed back on his preference for biotech and capital-market stocks over regional banks.

Technology and small caps were testing an old dividing line. Zarling found a clearer choice inside the small-cap index: biotechnology rather than regional banks.

Some U.S. operators were breaking a two-year pattern. Aurora Cannabis still couldn’t put in a higher low. Lund explained what an earlier loss had taught him about buying the industry’s story.

A breakout in small caps raised two possibilities for Brian Lund: money could rotate away from the leaders, or the laggards could join them. He was watching biotech for evidence.

Wald was comfortable with large technology stocks leading in November 2023. His concern was whether smaller companies could join the advance, with regional banks and software offering possible routes to broader strength.

The November rally had broadened, but Zaccardi was already watching for a change in leadership around the turn of the year. Retail, biotech and regional banks were on his list.

A viewer spotted a decade-long base in Marathon Oil. Parets saw an even longer one, but the strength he wanted was in Marathon Petroleum.
Page 2 · 19 ideas
Previous ideasNext ideas